Ultravist 150 and Cough - a phase IV clinical study of FDA data

Summary:

Cough is reported as a side effect among people who take Ultravist 150 (iopromide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Glucagon, and have Computerised tomogram abdomen.

The phase IV clinical study analyzes which people have Cough when taking Ultravist 150. It is created by eHealthMe based on reports of 1,345 people who have side effects when taking Ultravist 150 from the FDA, and is updated regularly.

What is Ultravist 150?

Ultravist 150 has active ingredients of iopromide. eHealthMe is studying from 1,345 Ultravist 150 users. Check the latest studies of Ultravist 150.

What is Cough?

Cough is found to be associated with 3,054 drugs and 3,800 conditions by eHealthMe. Check the latest studies of Cough.

On Jul, 09, 2026

1,345 people reported to have side effects when taking Ultravist 150.
Among them, 48 people (3.57%) have Cough.

Among these 48 people:

How long have people been on Ultravist 150 when they have Cough? *

What is the gender of people who have Cough when taking Ultravist 150? *

female: 79.55 %
male: 20.45 %

What is the age of people who have Cough when taking Ultravist 150? *

What are other drugs people take besides Ultravist 150? *

What are other side effects people have besides Cough? *

Sneezing: 20 people, 41.67%
Dyspnea (difficult or laboured breathing): 14 people, 29.17%
Urticaria (rash of round, red welts on the skin that itch intensely): 14 people, 29.17%
Rashes (redness): 9 people, 18.75%
Throat Irritation: 8 people, 16.67%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 8 people, 16.67%
Nausea And Vomiting: 6 people, 12.50%
Chest Pain: 6 people, 12.50%
Throat Tightness: 6 people, 12.50%
Nausea (feeling of having an urge to vomit): 5 people, 10.42%

What are the existing conditions these people have? *

Computerised Tomogram Abdomen: 13 people, 27.08%
Allergies: 4 people, 8.33%
Hepatic Neoplasm Malignant (liver cancer): 1 person, 2.08%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 1 person, 2.08%
Diabetes: 1 person, 2.08%
Abdominal Discomfort: 1 person, 2.08%

* Approximation only. Some reports may have incomplete information.

Do you take Ultravist 150 and have Cough?

- Check whether Cough is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ultravist 150:

Ultravist 150 (1,345 reports)

Cough treatments and more:

Cough (361,791 reports)

Browse all side effects of Ultravist 150:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cough:

Cough (3,054 drugs)

Browse all the conditions that are associated with Cough:

Cough (3,800 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on iopromide (the active ingredients of Ultravist 150) and Ultravist 150 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.